Mitsuru Miyaji

Discovery of the First Potent and Selective Small Molecule Opioid Receptor-like (ORL1) Antagonist:  1-[(3<i>R</i>,4<i>R</i>)-1-Cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl- 1,3-dihydro-2<i>H</i>-benzimidazol-2-one (J-113397)

Hiroshi Kawamoto, Satoshi Ozaki, Yoshiki Itoh et al. · Journal of Medicinal Chemistry · 1999 · 204 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist

Satoshi Ozaki, Hiroshi Kawamoto, Yoshiki Itoh et al. · European Journal of Pharmacology · 2000 · 167 citations

Medicine, Medicinal Chemistry, Pharmacology +7

A potent and highly selective nonpeptidyl nociceptin/orphanin FQ receptor (ORL1) antagonist: J-113397

Satoshi Ozaki, Hiroshi Kawamoto, Yoshiki Itoh et al. · European Journal of Pharmacology · 2000 · 73 citations

Medicine, Medicinal Chemistry, Pharmacology +8

Two Endothelin Receptor Subtypes in Porcine Arteries

M. Ihara, Toshihiko Saeki, Kaoru Funabashi et al. · Journal of Cardiovascular Pharmacology · 1991 · 49 citations

Life Sciences, Pharmacology, Physiology +13

Milrinone, a phosphodiesterase inhibitor, suppresses intimal thickening after photochemically induced endothelial injury in the mouse femoral artery

Kazunao Kondo, Kazuo Umemura, Mitsuru Miyaji et al. · Atherosclerosis · 1999 · 30 citations

Veterinary Medicine, Cardiology, Pharmacology +14